Protara Therapeutics Inc (TARA) — Capital Reinvestment Ratio

Latest as of September 2023: 0.29x

Protara Therapeutics Inc (TARA) has a Capital Reinvestment Ratio of 0.29x as of September 2023, meaning it reinvests 0% of its operating cash flow ($128.00K) in capital expenditures ($37.00K). Check TARA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.29x

Capex / Operating Cash Flow

Operating Cash Flow

$128.00K

USD

Capital Expenditures

$37.00K

USD

Data as of

Sep 2023

Most recent filing

Annual Capital Reinvestment Ratio for Protara Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Protara Therapeutics Inc from None to None. See TARA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow